These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic. Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094 [TBL] [Abstract][Full Text] [Related]
11. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series. Ioja E; Tóth G; Benyhe S; Tourwe D; Péter A; Tömböly C; Borsodi A Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734 [TBL] [Abstract][Full Text] [Related]
14. Endomorphin analogues with mixed μ-opioid (MOP) receptor agonism/δ-opioid (DOP) receptor antagonism and lacking β-arrestin2 recruitment activity. Cai J; Song B; Cai Y; Ma Y; Lam AL; Magiera J; Sekar S; Wyse BD; Ambo A; Sasaki Y; Lazarus LH; Smith MT; Li T Bioorg Med Chem; 2014 Apr; 22(7):2208-19. PubMed ID: 24613457 [TBL] [Abstract][Full Text] [Related]
15. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4. Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136 [TBL] [Abstract][Full Text] [Related]